Report - Acrux (ASX: ACR)investors.acrux.com.au/FormBuilder/_Resource/_module/NFYtO6lmR… · 12/11/2014  · • TSBC - Suboptimal responders to other testosterone gels –Phase IV, 75 men

Please pass captcha verification before submit form